Stay updated with breaking news from Genomics Stock. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Eagle Asset Management Inc. trimmed its position in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 0.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 729,476 shares of the company’s stock after selling 5,710 shares during the period. Eagle […]
10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) CEO Serge Saxonov sold 4,877 shares of the company’s stock in a transaction on Wednesday, May 22nd. The stock was sold at an average price of $24.30, for a total value of $118,511.10. Following the transaction, the chief executive officer now owns 889,641 shares of the company’s […]
TD Cowen cut shares of 10x Genomics (NASDAQ:TXG – Free Report) from a buy rating to a hold rating in a research note released on Wednesday morning, MarketBeat reports. The brokerage currently has $32.00 target price on the stock, down from their previous target price of $57.00. TXG has been the subject of several other […]
10x Genomics (NASDAQ:TXG – Free Report) had its price objective trimmed by Stifel Nicolaus from $63.00 to $53.00 in a report published on Wednesday, Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities analysts have also recently issued research reports about the stock. Canaccord Genuity Group reduced their price target […]
10x Genomics (NASDAQ:TXG – Free Report) had its price objective lowered by Stifel Nicolaus from $63.00 to $53.00 in a research note released on Wednesday, Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Several other research analysts also recently issued reports on TXG. TD Cowen downgraded 10x Genomics from a buy […]